Skip to main content
OpenTrials
Completed

NCT Number: NCT01298479

Sayana-Uniject Volumetric Delivery

The purpose of this study is to determine the volumetric delivery of the Uniject.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Volume Delivery

Age range

18 year–65 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Pfizer Investigational Site

Brussels, B-1070, Belgium

About this study

Observe subjects deliver the drug None used

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Nurses

Exclusion criteria

  • Non-nurses

Treatment and study plan

Uniject

Other

single use container

Primary outcomes

  1. Weight of drug suspension delivered (estimated by change in mass of the Uniject(TM) delivery system).

    Time frame: Visit 1

Sponsors and collaborators

Lead sponsor

Pfizer

Industry

Registry information

Official study title

Quantitative Determination of the Volume of Suspension Delivered Via the Uniject Delivery System Following Simulated Subcutaneous Injection by Healthcare Professionals Into a Synthetic Subcutaneous Injection Training Device

Important dates

Study start
2010
Primary completion
2010
Study completion
2010
First posted
Feb 17, 2011
Registry last updated
Dec 7, 2018

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.